Sa2082 SGLT2 INHIBITOR THERAPY REDUCES ARRHYTHMIA BURDEN AND ICD SHOCKS IN MASLD PATIENTS WITH HFPEF AND ATRIAL FIBRILLATION: A MULTI-CENTER REAL-WORLD STUDY | Synapse
Sa2082 SGLT2 INHIBITOR THERAPY REDUCES ARRHYTHMIA BURDEN AND ICD SHOCKS IN MASLD PATIENTS WITH HFPEF AND ATRIAL FIBRILLATION: A MULTI-CENTER REAL-WORLD STUDY
Key Points
Key points are not available for this paper at this time.